Literature DB >> 32179885

Maternal Supplementation of Inositols, Fucoxanthin, and Hydroxytyrosol in Pregnant Murine Models of Hypertension.

Daniela Menichini1,2, Mesk Alrais1, Chen Liu3, Yang Xia3, Sean C Blackwell1, Fabio Facchinetti4, Baha M Sibai1, Monica Longo1.   

Abstract

BACKGROUND: Myoinositol (M) and D-chiro-inositol (D) are insulin sensitizer compounds, while fucoxanthin (F) and hydroxytyrosol (H) are antioxidant substances. We aim to investigate if the combination of these compounds, will improve the vascular responses in pregnant mouse models of hypertension: a genetic model, transgenic heterozygous mice lacking endothelial nitric oxide synthase gene (eNOS-/+); and environmental, wild-type (WT) mice. Those mouse models will allow a better understanding of the genetic/environmental contribution to hypertension in pregnancy.
METHODS: eNOS-/+ and WT female were fed high fat diet for 4 weeks, then at 7-8 weeks of age were mated with WT male. On gestational day (GD) 1, they were randomly allocated to receive MDFH treatment or water as control: eNOS-/+ MDFH (n = 13), eNOS-/+ (n = 13), WT-MDFH (n = 14), and WT (n = 20). Systolic blood pressure (SBP) was obtained at GD 18, then dams were sacrificed; fetuses and placentas collected, and 2 mm segments of carotid arteries isolated for vascular responses using the wire-myograph system. Responses to phenylephrine (PE), with/without the NOS inhibitor (N-nitro-l-arginine methyl ester (l-NAME)), and to acetylcholine (Ach) and sodium nitroprussiate (SNP) were performed.
RESULTS: SBP decreased in eNOS-/+ and WT dams after MDFH supplementation. In eNOS-/+, MDFH lower the contractile response to PE and l-NAME and improved Ach vasorelaxation. In WT dams, MDFH treatment did not affect PE response; MDFH treatment lowered the vascular PE response after incubation with l-NAME. No differences were seen in SNP relaxation in both models.
CONCLUSIONS: MDFH decreased SBP in both genetically and environmentally hypertensive dams and improved vascular responses mostly in the eNOS-/+ dams. © American Journal of Hypertension, Ltd 2020. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; endothelial nitric oxide synthase; fucoxanthin; high fat diet; hydroxytyrosol; hypertension; inositol; obesity; pregnancy

Mesh:

Substances:

Year:  2020        PMID: 32179885     DOI: 10.1093/ajh/hpaa041

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  3 in total

Review 1.  The Critical Studies of Fucoxanthin Research Trends from 1928 to June 2021: A Bibliometric Review.

Authors:  Yam Sim Khaw; Fatimah Md Yusoff; Hui Teng Tan; Nur Amirah Izyan Noor Mazli; Muhammad Farhan Nazarudin; Noor Azmi Shaharuddin; Abdul Rahman Omar
Journal:  Mar Drugs       Date:  2021-10-26       Impact factor: 5.118

2.  Protective Effects of Fucoxanthin on Hydrogen Peroxide-Induced Calcification of Heart Valve Interstitial Cells.

Authors:  Yi-Fen Chiang; Chih-Hung Tsai; Hsin-Yuan Chen; Kai-Lee Wang; Hsin-Yi Chang; Yun-Ju Huang; Yong-Han Hong; Mohamed Ali; Tzong-Ming Shieh; Tsui-Chin Huang; Ching-I Lin; Shih-Min Hsia
Journal:  Mar Drugs       Date:  2021-05-26       Impact factor: 5.118

3.  Metabonomics Study on the Infertility Treated With Zishen Yutai Pills Combined With In Vitro Fertilization-embryo Transfer.

Authors:  Li Li; Na Ning; Jian-An Wei; Qiu-Ling Huang; Yue Lu; Xiu-Fei Pang; Jing-Jing Wu; Jie-Bin Zhou; Jie-Wen Zhou; Guo-An Luo; Ling Han
Journal:  Front Pharmacol       Date:  2021-07-19       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.